166 related articles for article (PubMed ID: 29422251)
1. Systematic review of current prognostication systems for primary gastrointestinal stromal tumors.
Khoo CY; Chai X; Quek R; Teo MCC; Goh BKP
Eur J Surg Oncol; 2018 Apr; 44(4):388-394. PubMed ID: 29422251
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen.
Belfiori G; Sartelli M; Cardinali L; Tranà C; Bracci R; Gesuita R; Marmorale C
Ann Ital Chir; 2015; 86(3):219-27. PubMed ID: 26098671
[TBL] [Abstract][Full Text] [Related]
3. Performance of risk stratification systems for gastrointestinal stromal tumors: A multicenter study.
Chen T; Ye LY; Feng XY; Qiu HB; Zhang P; Luo YX; Yuan LY; Chen XH; Hu YF; Liu H; Li Y; Tao KX; Yu J; Li GX
World J Gastroenterol; 2019 Mar; 25(10):1238-1247. PubMed ID: 30886506
[TBL] [Abstract][Full Text] [Related]
4. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
[TBL] [Abstract][Full Text] [Related]
5. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
[TBL] [Abstract][Full Text] [Related]
6. Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients.
Chok AY; Goh BK; Koh YX; Lye WK; Allen JC; Quek R; Teo MC; Chow PK; Ong HS; Chung AY; Wong WK
Ann Surg Oncol; 2015 Oct; 22(11):3597-605. PubMed ID: 25652053
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
[TBL] [Abstract][Full Text] [Related]
8. The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumors.
Racz JM; Brar SS; Cleghorn MC; Jimenez MC; Azin A; Atenafu EG; Jackson TD; Okrainec A; Quereshy FA
J Surg Oncol; 2015 Mar; 111(4):371-6. PubMed ID: 25501790
[TBL] [Abstract][Full Text] [Related]
9. The assessment of different risk classification systems for gastrointestinal stromal tumors (GISTs): the analytic results from the SEER database.
Zhao B; Zhang J; Mei D; Zhang J; Luo R; Xu H; Huang B
Scand J Gastroenterol; 2018; 53(10-11):1319-1327. PubMed ID: 30353759
[TBL] [Abstract][Full Text] [Related]
10. A nomogram to predict disease-free survival after surgical resection of GIST.
Bischof DA; Kim Y; Behman R; Karanicolas PJ; Quereshy FA; Blazer DG; Maithel SK; Gamblin TC; Bauer TW; Pawlik TM
J Gastrointest Surg; 2014 Dec; 18(12):2123-9. PubMed ID: 25245766
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
[TBL] [Abstract][Full Text] [Related]
12. [Past and present of risk stratification of gastrointestinal stromal tumors and its clinical value].
Zhang MQ; Qiu HB; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):845-851. PubMed ID: 32927507
[TBL] [Abstract][Full Text] [Related]
13. Comparison of prognostic prediction models for rectal gastrointestinal stromal tumor.
Jiaxin L; Peiyun Z; Zheng T; Wei Y; Shanshan S; Lei R; Zhengwen X; Yong F; Xiaodong G; Anwei X; Kuntang S; Yingyong H
Aging (Albany NY); 2020 Jun; 12(12):11416-11430. PubMed ID: 32561689
[TBL] [Abstract][Full Text] [Related]
14. Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy.
Yanagimoto Y; Takahashi T; Muguruma K; Toyokawa T; Kusanagi H; Omori T; Masuzawa T; Tanaka K; Hirota S; Nishida T
Gastric Cancer; 2015 Apr; 18(2):426-33. PubMed ID: 24853473
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.
Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K
EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of modified NIH and AFIP risk-stratification criteria for gastrointestinal stromal tumors: A multicenter retrospective study].
Chen T; Qiou H; Feng X; Zhang P; Ye L; Hu Y; Liu H; Yu J; Tao K; Li Y; Zhou Z; Li G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1020-1024. PubMed ID: 28900993
[TBL] [Abstract][Full Text] [Related]
17. Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.
Li S; Chen D; Li S; Zhao Z; Yang H; Wang D; Zhang Z; Fu W
Front Oncol; 2020; 10():581855. PubMed ID: 33585198
[TBL] [Abstract][Full Text] [Related]
18. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
[TBL] [Abstract][Full Text] [Related]
19. Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients.
Bischof DA; Kim Y; Dodson R; Jimenez MC; Behman R; Cocieru A; Fisher SB; Groeschl RT; Squires MH; Maithel SK; Blazer DG; Kooby DA; Gamblin TC; Bauer TW; Quereshy FA; Karanicolas PJ; Law CH; Pawlik TM
JAMA Surg; 2015 Apr; 150(4):299-306. PubMed ID: 25671681
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three prognostic models for predicting cancer-specific survival among patients with gastrointestinal stromal tumors.
Oweira H; Schmidt J; Mehrabi A; Kulaksiz H; Schneider P; Schöb O; Giryes A; Abdel-Rahman O
Future Oncol; 2018 Feb; 14(4):379-389. PubMed ID: 29318911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
